Published: May 03, 2021 KIRKLAND, WA – May 3, 2021 -- Amcyte Pharma, a Seattle-based company dedicated to the commercialization of immunomodulators, announced the results of an independent clinical trial among ICU staff suggesting that its product, Nasitrol TM nasal spray, represents a safe and effective treatment that could prevent transmission of COVID-19. Amcyte will market Nasitrol in the U.S. through a licensing agreement from Laboratorio Pablo Cassara, an Argentinean pharma company leader in innovation. Nasitrol is a patented nasal spray based on iota carrageenan, a sulfate polys...